SANA vs DNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

SANA

56.1
AI Score
VS
SANA Wins

DNA

53.0
AI Score

Investment Advisor Scores

SANA

56score
Recommendation
HOLD

DNA

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SANA DNA Winner
Net Income -47.21M -313,000 DNA
Operating Income -48.61M -315.28M SANA
ROE -39.6% -0.1% DNA
ROA -12.6% -0.0% DNA
Total Assets 373.59M 1.12B DNA
Cash 83.80M 167.20M DNA
Current Ratio 1.29 4.92 DNA
Free Cash Flow -37.67M -178.72M SANA

Relative Price Performance (Last 90 Days)

SANA 1M: -20.7% · 3M: -2.8% DNA 1M: -14.0% · 3M: -7.8%

Current Technical Phase

SANA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.5 · Price: $3.18

DNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.4 · Price: $8.94

Fundamentals Snapshot

Metric SANA DNA
Market Cap
Forward P/E -6.1 -2.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.5%
Gross Margin 0.7%
Operating Margin 0.0% -3.7%
EPS -0.92 -5.38
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SANA is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.